IRIS Accounts Production v25.1.3.33 07976699 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh079766992023-03-31079766992024-03-31079766992023-04-012024-03-31079766992022-03-31079766992022-04-012023-03-31079766992023-03-3107976699ns15:EnglandWales2023-04-012024-03-3107976699ns14:PoundSterling2023-04-012024-03-3107976699ns10:Director12023-04-012024-03-3107976699ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3107976699ns10:SmallEntities2023-04-012024-03-3107976699ns10:AuditExemptWithAccountantsReport2023-04-012024-03-3107976699ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3107976699ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3107976699ns10:FullAccounts2023-04-012024-03-3107976699ns10:OrdinaryShareClass12023-04-012024-03-3107976699ns10:Director22023-04-012024-03-3107976699ns10:Director32023-04-012024-03-3107976699ns10:RegisteredOffice2023-04-012024-03-3107976699ns5:CurrentFinancialInstruments2024-03-3107976699ns5:CurrentFinancialInstruments2023-03-3107976699ns5:Non-currentFinancialInstruments2024-03-3107976699ns5:Non-currentFinancialInstruments2023-03-3107976699ns5:ShareCapital2024-03-3107976699ns5:ShareCapital2023-03-3107976699ns5:RetainedEarningsAccumulatedLosses2024-03-3107976699ns5:RetainedEarningsAccumulatedLosses2023-03-3107976699ns5:LandBuildingsns5:OwnedOrFreeholdAssets2023-04-012024-03-3107976699ns5:LongLeaseholdAssetsns5:LandBuildings2023-04-012024-03-3107976699ns5:PlantMachinery2023-04-012024-03-3107976699ns5:FurnitureFittings2023-04-012024-03-3107976699ns5:ComputerEquipment2023-04-012024-03-3107976699ns5:LandBuildings2023-03-3107976699ns5:LongLeaseholdAssetsns5:LandBuildings2023-03-3107976699ns5:PlantMachinery2023-03-3107976699ns5:LandBuildings2023-04-012024-03-3107976699ns5:LandBuildings2024-03-3107976699ns5:LongLeaseholdAssetsns5:LandBuildings2024-03-3107976699ns5:PlantMachinery2024-03-3107976699ns5:LandBuildings2023-03-3107976699ns5:LongLeaseholdAssetsns5:LandBuildings2023-03-3107976699ns5:PlantMachinery2023-03-3107976699ns5:FurnitureFittings2023-03-3107976699ns5:ComputerEquipment2023-03-3107976699ns5:FurnitureFittings2024-03-3107976699ns5:ComputerEquipment2024-03-3107976699ns5:FurnitureFittings2023-03-3107976699ns5:ComputerEquipment2023-03-3107976699ns5:UnlistedNon-exchangeTradedns5:CostValuation2023-03-3107976699ns5:UnlistedNon-exchangeTraded2024-03-3107976699ns5:UnlistedNon-exchangeTraded2023-03-3107976699ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-03-3107976699ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-03-3107976699ns5:Secured2024-03-3107976699ns5:Secured2023-03-3107976699ns10:OrdinaryShareClass12024-03-31
REGISTERED NUMBER: 07976699 (England and Wales)














Unaudited Financial Statements

for the Year Ended 31 March 2024

for

The Botanical Extract Company Limited

The Botanical Extract Company Limited (Registered number: 07976699)

Contents of the Financial Statements
for the Year Ended 31 March 2024










Page

Company information 1

Chartered accountants' report 2

Statement of financial position 3 to 4

Notes to the financial statements 5 to 8


The Botanical Extract Company Limited

Company Information
for the Year Ended 31 March 2024







Directors: S R Copeman Carter
A Broughton
T Copeman Carter





Registered office: 103 High Street
Syston
Leicester
LE7 1GQ





Registered number: 07976699 (England and Wales)





Accountants: Moore Thompson
Bank House
Broad Street
Spalding
Lincolnshire
PE11 1TB

Chartered Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
The Botanical Extract Company Limited


The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Statement of financial position. Readers are cautioned that the Income statement and certain other primary statements and the Report of the directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of The Botanical Extract Company Limited for the year ended 31 March 2024 which comprise the Statement of income and retained earnings, Statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of The Botanical Extract Company Limited, as a body, in accordance with the terms of our engagement letter dated 8 August 2024. Our work has been undertaken solely to prepare for your approval the financial statements of The Botanical Extract Company Limited and state those matters that we have agreed to state to the Board of Directors of The Botanical Extract Company Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than The Botanical Extract Company Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that The Botanical Extract Company Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of The Botanical Extract Company Limited. You consider that The Botanical Extract Company Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of The Botanical Extract Company Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Moore Thompson
Bank House
Broad Street
Spalding
Lincolnshire
PE11 1TB


20 May 2025

The Botanical Extract Company Limited (Registered number: 07976699)

Statement of Financial Position
31 March 2024

2024 2023
Notes £    £    £   
Fixed assets
Tangible assets 5 720,631 707,313
Investments 6 100 100
720,731 707,413

Current assets
Stocks 285,657 297,973
Debtors 7 557,479 269,628
Cash at bank 11,937 117,962
855,073 685,563
Creditors
Amounts falling due within one year 8 492,466 351,424
Net current assets 362,607 334,139
Total assets less current liabilities 1,083,338 1,041,552

Creditors
Amounts falling due after more than one
year

9

(577,508

)

(717,300

)

Provisions for liabilities (90,460 ) -
Net assets 415,370 324,252

Capital and reserves
Called up share capital 11 100 100
Retained earnings 415,270 324,152
Shareholders' funds 415,370 324,252

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The Botanical Extract Company Limited (Registered number: 07976699)

Statement of Financial Position - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of income and retained earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 May 2025 and were signed on its behalf by:





T Copeman Carter - Director


The Botanical Extract Company Limited (Registered number: 07976699)

Notes to the Financial Statements
for the Year Ended 31 March 2024


1. Statutory information

The Botanical Extract Company Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. Accounting policies

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - Not depreciated
Long leasehold - 25% on reducing balance
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on a straight line basis

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

The Botanical Extract Company Limited (Registered number: 07976699)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


3. Accounting policies - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

4. Employees and directors

The average number of employees during the year was 13 (2023 - 13 ) .

5. Tangible fixed assets
Freehold Long Plant and
property leasehold machinery
£    £    £   
Cost
At 1 April 2023 356,840 16,776 831,851
Additions - - 129,910
At 31 March 2024 356,840 16,776 961,761
Depreciation
At 1 April 2023 - 15,682 497,899
Charge for year - 274 115,965
At 31 March 2024 - 15,956 613,864
Net book value
At 31 March 2024 356,840 820 347,897
At 31 March 2023 356,840 1,094 333,952

Fixtures
and Computer
fittings equipment Totals
£    £    £   
Cost
At 1 April 2023 40,308 13,165 1,258,940
Additions 4,673 - 134,583
At 31 March 2024 44,981 13,165 1,393,523
Depreciation
At 1 April 2023 24,882 13,164 551,627
Charge for year 5,025 1 121,265
At 31 March 2024 29,907 13,165 672,892
Net book value
At 31 March 2024 15,074 - 720,631
At 31 March 2023 15,426 1 707,313

The Botanical Extract Company Limited (Registered number: 07976699)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


6. Fixed asset investments
Unlisted
investments
£   
Cost
At 1 April 2023
and 31 March 2024 100
Net book value
At 31 March 2024 100
At 31 March 2023 100

7. Debtors: amounts falling due within one year
2024 2023
£    £   
Trade debtors 557,479 269,628

8. Creditors: amounts falling due within one year
2024 2023
£    £   
Bank loans and overdrafts 31,506 -
Trade creditors 260,739 234,678
Corporation tax 72,571 12,226
Social security and other taxes 4,834 5,397
VAT 45,480 45,873
Other creditors - 50,000
Directors' loan accounts 73,736 -
Accruals and deferred income 3,600 3,250
492,466 351,424

9. Creditors: amounts falling due after more than one year
2024 2023
£    £   
Bank loans 228,890 242,300
Other creditors 348,618 475,000
577,508 717,300

10. Secured debts

The following secured debts are included within creditors:

2024 2023
£    £   
Bank loans 260,396 242,300

The Botanical Extract Company Limited (Registered number: 07976699)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


11. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

12. Related party disclosures

During the hear the following sales were made to related parties:

Planta Medica (Co-Op) Limited - £444,712

Plant Preparations Limited - £2,376

The following related party debtor balances were outstanding at the year end:

Planta Medica (Co-Op) Limited - £158,750

Plant Preparations Limited - £5,870

There was also a loan made to Plant Preparation Limited which at the year end was £206,583.